198 related articles for article (PubMed ID: 8993975)
1. Evaluation of MYC and chromosome 8 copy number in breast carcinoma by interphase cytogenetics.
Visscher DW; Wallis T; Awussah S; Mohamed A; Crissman JD
Genes Chromosomes Cancer; 1997 Jan; 18(1):1-7. PubMed ID: 8993975
[TBL] [Abstract][Full Text] [Related]
2. Determination of Her-2/Neu status in breast carcinoma: comparative analysis of immunohistochemistry and fluorescent in situ hybridization.
Jimenez RE; Wallis T; Tabasczka P; Visscher DW
Mod Pathol; 2000 Jan; 13(1):37-45. PubMed ID: 10658908
[TBL] [Abstract][Full Text] [Related]
3. Chromosome 8 numerical aberration and C-MYC copy number gain in bladder cancer are linked to stage and grade.
Mahdy E; Pan Y; Wang N; Malmström PU; Ekman P; Bergerheim U
Anticancer Res; 2001; 21(5):3167-73. PubMed ID: 11848469
[TBL] [Abstract][Full Text] [Related]
4. Karyotypic heterogeneity and its relation to labeling index in interphase breast tumor cells.
Balazs M; Matsumura K; Moore D; Pinkel D; Gray JW; Waldman FM
Cytometry; 1995 May; 20(1):62-73. PubMed ID: 7600900
[TBL] [Abstract][Full Text] [Related]
5. Analysis of chromosome aneuploidy in breast carcinoma progression by using fluorescence in situ hybridization.
Mendelin J; Grayson M; Wallis T; Visscher DW
Lab Invest; 1999 Apr; 79(4):387-93. PubMed ID: 10211991
[TBL] [Abstract][Full Text] [Related]
6. Association of C-MYC amplification with progression from the in situ to the invasive stage in C-MYC-amplified breast carcinomas.
Robanus-Maandag EC; Bosch CA; Kristel PM; Hart AA; Faneyte IF; Nederlof PM; Peterse JL; van de Vijver MJ
J Pathol; 2003 Sep; 201(1):75-82. PubMed ID: 12950019
[TBL] [Abstract][Full Text] [Related]
7. [Detection of chromosomal aberration using fluorescence in situ hybridization on breast cancer].
Iwamoto S; Okajima K; Ryo T; Ishibashi T; Toyoda M; Ichinona T; Osada K; Gon G
Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():192-6. PubMed ID: 7611789
[TBL] [Abstract][Full Text] [Related]
8. Detection of c-myc amplification in uveal melanoma by fluorescent in situ hybridization.
Parrella P; Caballero OL; Sidransky D; Merbs SL
Invest Ophthalmol Vis Sci; 2001 Jul; 42(8):1679-84. PubMed ID: 11431428
[TBL] [Abstract][Full Text] [Related]
9. Flow-cytometric quantification in human gliomas of alpha satellite DNA sequences specific for chromosome 7 using fluorescence in situ hybridization.
Kwak T; Nishizaki T; Ito H; Kimura Y; Murakami T; Sasaki K
Cytometry; 1994 Sep; 17(1):26-32. PubMed ID: 8001457
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of c-MYC status in primary acquired cholesteatoma by using fluorescence in situ hybridization technique.
Ozturk K; Yildirim MS; Acar H; Cenik Z; Keles B
Otol Neurotol; 2006 Aug; 27(5):588-91. PubMed ID: 16868505
[TBL] [Abstract][Full Text] [Related]
11. Quantitation of HER-2/neu and c-myc gene amplification in breast carcinoma using fluorescence in situ hybridization.
Persons DL; Borelli KA; Hsu PH
Mod Pathol; 1997 Jul; 10(7):720-7. PubMed ID: 9237184
[TBL] [Abstract][Full Text] [Related]
12. Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization.
Jenkins RB; Qian J; Lieber MM; Bostwick DG
Cancer Res; 1997 Feb; 57(3):524-31. PubMed ID: 9012485
[TBL] [Abstract][Full Text] [Related]
13. Phyllodes tumors of the breast analyzed by comparative genomic hybridization and association of increased 1q copy number with stromal overgrowth and recurrence.
Lu YJ; Birdsall S; Osin P; Gusterson B; Shipley J
Genes Chromosomes Cancer; 1997 Nov; 20(3):275-81. PubMed ID: 9365835
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer in males: DNA content and sex chromosome constitution.
Wolman SR; Sanford J; Ratner S; Dawson PJ
Mod Pathol; 1995 Apr; 8(3):239-43. PubMed ID: 7617646
[TBL] [Abstract][Full Text] [Related]
15. Interphase cytogenetics in oncocytic adenomas and carcinomas of the thyroid gland.
Mazzucchelli L; Burckhardt E; Hirsiger H; Kappeler A; Laissue JA
Hum Pathol; 2000 Jul; 31(7):854-9. PubMed ID: 10923924
[TBL] [Abstract][Full Text] [Related]
16. Determination of HER2 amplification by in situ hybridization: when should chromosome 17 also be determined?
Bartlett JM; Campbell FM; Mallon EA
Am J Clin Pathol; 2008 Dec; 130(6):920-6. PubMed ID: 19019769
[TBL] [Abstract][Full Text] [Related]
17. Quantitative FISH by image cytometry for the detection of chromosome 1 imbalances in breast cancer: a novel approach analyzing chromosome rearrangements within interphase nuclei.
Truong K; Guilly MN; Gerbault-Seureau M; Malfoy B; Vielh P; Bourgeois CA; Dutrillaux B
Lab Invest; 1998 Dec; 78(12):1607-13. PubMed ID: 9881960
[TBL] [Abstract][Full Text] [Related]
18. Amplification of c-myc by fluorescence in situ hybridization in a population-based breast cancer tissue array.
Rummukainen JK; Salminen T; Lundin J; Kytölä S; Joensuu H; Isola JJ
Mod Pathol; 2001 Oct; 14(10):1030-5. PubMed ID: 11598174
[TBL] [Abstract][Full Text] [Related]
19. Detection of chromosome aneuploidy in interphase nuclei from human primary breast tumors using chromosome-specific repetitive DNA probes.
Devilee P; Thierry RF; Kievits T; Kolluri R; Hopman AH; Willard HF; Pearson PL; Cornelisse CJ
Cancer Res; 1988 Oct; 48(20):5825-30. PubMed ID: 3167839
[TBL] [Abstract][Full Text] [Related]
20. Analysis of chromosome aneuploidy in ovarian dysgerminoma by flow cytometry and fluorescence in situ hybridization.
Gibas Z; Talerman A
Diagn Mol Pathol; 1993 Mar; 2(1):50-6. PubMed ID: 8287226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
